COMMUNIQUÉS West-GlobeNewswire

Replimune to Present at Two Upcoming Investor Conferences

07/02/2019 - 14:00

WOBURN, Mass., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immunotherapies derived from its Immulytic™ platform, today announced that Robert Coffin [...]

Adaptimmune to Report Fourth Quarter / Full Year 2018 Financial Results and Business Update on Wednesday, February 27, 2019

07/02/2019 - 14:00

PHILADELPHIA and OXFORD, United Kingdom, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, will announce financial results for the Fourth Quarter [...]

Sport Endurance Signs Letter of Intent to Acquire CBD Animal Health and Wellness Company, Bona Vida

07/02/2019 - 14:00

BROOKLYN, N.Y., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTCQB: SENZ) (the “Company”), to be reincorporated as Better Choice Company, Inc., today announced that it has signed a Letter of Intent (“LOI”) [...]

CTD Reports Initial Data for Two Clinical Trials of Trappsol® Cyclo™ Provided Intravenously for Patients with Niemann-Pick Disease Type C

07/02/2019 - 14:00

ALACHUA, Fla., Feb. 07, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, [...]

Arch Biopartners Awarded NRC-IRAP Funding to Further Develop Metablok Drug Program

07/02/2019 - 14:00

TORONTO, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), today announced that the National Research Council – Industrial Research Assistance [...]

VBI Vaccines Announces Third Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent GBM Patients

07/02/2019 - 14:00

Independent Data and Safety Monitoring Board (DSMB) unanimously recommends continuation of the study without modification Enrollment is complete in the high-dose study arm of Part A Expanded immunologic data and 6-month [...]

InspireMD to Report Fourth Quarter and Fiscal 2018 Financial Results and Provide Business Update on Tuesday, February 19

07/02/2019 - 14:00

Conference Call Scheduled for 8am Eastern Time TEL AVIV, Israel, Feb. 07, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of [...]

Avadel Pharmaceuticals Announces Restructuring to Focus on FT218 Clinical Development Program

07/02/2019 - 14:00

- Company cost structure expected to be reduced by $70 to $75 million in 2019 – - Approximately $100 million in cash and marketable securities at December 31, 2018 – DUBLIN, Ireland, Feb. 07, 2019 (GLOBE NEWSWIRE) -- [...]

Shockwave Appoints Laura Francis to Board of Directors

07/02/2019 - 14:00

SANTA CLARA, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, a pioneer in the development and commercialization of Intravascular Lithotripsy to treat complex calcified cardiovascular disease, today [...]

Agile Therapeutics to Present at the 2019 BIO CEO and Investor Conference

07/02/2019 - 14:00

PRINCETON, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today that its Chairman and Chief Executive Officer, Al Altomari will present at the [...]

Clinical update: Dovitinib DRP data mining successfully completed and new LiPlaCis data continues to support an FDA breakthrough designation strategy

07/02/2019 - 13:35

Press release Hoersholm, Denmark and Cambridge, MA, US, February 7, 2019 – Oncology Venture A/S (“OV” or “the Company”) today provides a clinical update on its precision drug projects. Oncology Venture has finalized the [...]

ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2018 Earnings Conference Call

07/02/2019 - 13:30

SAN CLEMENTE, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care [...]

Moleculin Announces Approval for Third Drug to Commence Clinical Trials

07/02/2019 - 13:30

MBRX will now have three distinctive oncology drugs in clinic in four ongoing clinical trials WP1220, a STAT3 inhibitor, to begin clinical trials in Poland for the treatment of Cutaneous T-Cell Lymphona (“CTCL”), a rare [...]

Meridian Launches New Range of Lyo-Ready PCR Mixes

07/02/2019 - 13:30

CINCINNATI, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that following the successful release of the Lyo-Ready qPCR Mix, Meridian is proud to introduce its next-generation [...]

Tabula Rasa HealthCare Announces Proposed $250 Million Offering of Convertible Notes

07/02/2019 - 13:21

MOORESTOWN, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) (“TRHC”) today announced its intention to offer, subject to market and other conditions, $250 million principal amount of [...]

Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2018 Financial Results on March 14, 2019

07/02/2019 - 13:05

NEWTOWN, Pa., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that fourth [...]

Medtronic Receives FDA Approval on Expanded Indication for Pipeline Flex Embolization Device

07/02/2019 - 13:01

Approval Based on Clinical Data from the PREMIER Trial - New Indication Provides Options for Patients with Small or Medium, Wide-Necked Brain Aneurysms DUBLIN - February 7, 2019 - Medtronic plc (NYSE:MDT) announced [...]

BeiGene to Present at the Guggenheim Healthcare Talks Idea Forum – Oncology Day

07/02/2019 - 13:00

CAMBRIDGE, Mass., and BEIJING, China, Feb. 07, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2018

07/02/2019 - 13:00

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]